Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating DNA, Circulating RNA, Circulating Tumor Cells

Circulating DNA, Circulating RNA, Circulating Tumor Cells

Date: Monday, 23 March 2015 - Tuesday, 24 March 2015
Location: Boston, USA

Keynote Speakers

Nitzan Rosenfeld

Nitzan Rosenfeld
Senior Group Leader, Cancer Research UK and CSO, Inivata Ltd.

Davina Gale

Davina Gale
Head of Molecular Diagnostics, Co-Founder, Inivata

Vincent Miller

Vincent Miller
Chief Medical Officer, Foundation Medicine

Doug Taylor

Doug Taylor
Chief Scientific Officer, Exosome Sciences Inc

Xandra Breakefield

Xandra Breakefield
Professor, Mass General Hospital (MGH)/Harvard Medical School

Frank Slack

Frank Slack
Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School

Yoshiya Oda

Yoshiya Oda
President, Eisai Inc

John Palma

John Palma
Chief Medical Officer, Roche Sequencing Solutions

Mark Sausen

Mark Sausen
Vice President, Research & Development, Personal Genome Diagnostics

David Wong

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Phil Stephens

Phil Stephens
Chief Scientific Officer, Foundation Medicine


This conference track within the SELECTBIO Circulating Biomarkers World Congress 2015 brings together topics relating to the study and utilization of Extracellular Nucleic Acids (such as circulating-free DNA and circulating RNA) as well as circulating tumor cells (CTCs) in biological fluids as a circulating biomarker class.

Recent work has demonstrated the potential for cfDNA as a proxy for monitoring tumor progression and there is a great deal of interest currently in the potential utilization of cfDNA as a means to genotype for cancer mutations and the utilization/deployment of targeted therapies targeting such mutations.  This topic will be explored in this conference track.  Additionally, the potential role of circulating RNA and its utility as a circulating biomarker will be discussed.

This track also brings in presentations focusing on circulating tumor cells (CTCs) as a biomarker for various cancer classes as a means to have a head-to-head discussion of the merits of cfDNA, Circulating RNA, as well as CTCs as oncology biomarkers for monitoring disease progression.

Agenda Topics

  • Circulating RNAs as a Potential Biomarker Class (Small RNAs such as microRNAs are an Attractive Biomarker Class)
  • Circulating Tumor Cells (CTCs): Methodologies for Isolation and Interrogation
    • Head-to-Head Comparison of CTCs with ctDNA as Circulating Biomarkers
  • Circulating Tumor DNA (ctDNA): Potential for Monitoring Disease Progression in Oncology
  • Circulating-Free DNA (cfDNA) as a Cancer Biomarker for Correctly Deploying Targeted Therapeutics and Enabling Personalized Medicine
  • Digital PCR Applications for Circulating Biomarker Interrogation
  • Methodologies for Isolating and Characterizing Extracellular Nucleic Acids (cfDNA, Extracellular RNA)
  • Tools and Technologies for Monitoring Extracellular Nucleic Acids in Biological Fluids

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Confirmed Speakers to date

Tania Konry, Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University
Martin Beaulieu, Director, Regulus Therapeutics Inc
Farideh Bischoff, Executive Director, Silicon Biosystems Inc
Cesar Castro, Director – Cancer Program, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School
Saumya Das, Assistant Professor in Medicine, Beth Israel Deaconess Medical Center and Mass General Hospital
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
Z Fan, Professor, University of Florida
Tony Godfrey, Associate Chair – Research, Department of Surgery, Boston University Medical Center
Kenneth Kotz, Assistant in Bioengineering & Instructor, Massachusetts General Hospital/Harvard Medical School
Pavan Kumar, Senior Scientist, Eisai Inc
Mike Makrigiorgos, Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School
Abhijit Patel, Associate Professor, Yale University School of Medicine
Meeta Patnaik, CMO, AXON Dx
Kristin Ciriello Pothier, Partner & Managing Director/Life Sciences Leader, Ernst and Young LLP
Lidong Qin, Professor and CPRIT Scholar, Houston Methodist Research Institute
Katherine Richardson, Vice President, Research & Development, Transgenomic, Inc.
Jeff Stoll, Vice President, Life Sciences, Ernst & Young LLP
Shannon Stott, Assistant Professor, Massachusetts General Hospital & Harvard Medical School
Alexander Wolf, Scientist, QIAGEN
Theresa Zhang, Vice President, Research Services, Personal Genome Diagnostics
Weian Zhao, Associate Professor, Department of Biomedical Engineering, University of California-Irvine

Corporate Sponsors Media Sponsors Networking

Add to Calendar ▼2015-03-23 00:00:002015-03-24 00:00:00Europe/LondonCirculating DNA, Circulating RNA, Circulating Tumor